Related Experiment Video

Updated: Jun 16, 2026

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers
06:02

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers

Published on: February 20, 2017

Nek4 status differentially alters sensitivity to distinct microtubule poisons

Jason Doles1, Michael T Hemann

  • 1Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.

Cancer Research
|January 28, 2010
PubMed

Insights

The NIMA kinase Nek4 influences cancer drug efficacy. Nek4 promotes microtubule stability with Taxol but enhances sensitivity to destabilizing drugs like vincristine, impacting cancer therapy choices.

Area of Science:

  • Oncology
  • Cell Biology
  • Biochemistry

Background:

  • Microtubule poisons are crucial cancer therapeutics.
  • The mechanisms dictating varying drug efficacy within this class are not fully understood.
  • Identifying novel mediators of drug response is essential for optimizing cancer treatment.

Purpose of the Study:

  • To identify genes that modify cellular responses to microtubule-targeting chemotherapy.
  • To investigate the role of NIMA kinase 4 (Nek4) in mediating responses to Taxol and vincristine.
  • To explore the potential of Nek4 as a biomarker for selecting appropriate microtubule poisons in cancer therapy.

Main Methods:

  • Conducted a genetic screen to identify mediators of Taxol response.
  • Utilized cell-based assays to assess the impact of Nek4 on microtubule dynamics and cell cycle progression.
  • Examined the effect of Nek4 deficiency on sensitivity to both microtubule-stabilizing (Taxol) and destabilizing (vincristine) agents.

Main Results:

  • Nek4 was identified as a key mediator of Taxol response.
  • Nek4 promotes microtubule outgrowth and G(2)-M arrest following Taxol treatment.
  • Nek4 deficiency sensitizes cells to vincristine, indicating a dual role dependent on microtubule polymerization status.
  • Nek4 gene deletion is observed at a locus frequently deleted in non-small cell lung cancer.

Conclusions:

  • Nek4 plays a critical, context-dependent role in modulating cellular responses to microtubule poisons.
  • Nek4's function suggests it can either enhance or counteract the effects of chemotherapy based on drug mechanism.
  • Nek4 status may inform the selection of specific microtubule poisons for treating non-small cell lung cancer.

More Related Videos

Spatiotemporal Subcellular Manipulation of the Microtubule Cytoskeleton in the Living Preimplantation Mouse Embryo using Photostatins08:13

Spatiotemporal Subcellular Manipulation of the Microtubule Cytoskeleton in the Living Preimplantation Mouse Embryo using Photostatins

Published on: November 30, 2021

Quantitative Microtubule Fractionation Technique to Separate Stable Microtubules, Labile Microtubules, and Free Tubulin in Mouse Tissues07:21

Quantitative Microtubule Fractionation Technique to Separate Stable Microtubules, Labile Microtubules, and Free Tubulin in Mouse Tissues

Published on: November 17, 2023

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
Microtubule Instability02:17

Microtubule Instability

Microtubules are hollow cylindrical filaments having a diameter of approximately 25 nm and a length that varies from 200 nm to 25 μm. GTP-bound tubulin subunits form αβ-heterodimers for microtubule assembly. These core building blocks interact longitudinally, polymerizing into protofilaments. The protofilaments then interact with one another through lateral bonding forces to form stable cylindrical microtubules. These cylindrical filaments are dynamic as they undergo repeated assembly and...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...